Search - tctmd.com

Displaying 241 - 260 of 397

Sort: Relevancy | Date

News Industry News

MHRA review confirms benefit-risk profile of Alteplase - the only licensed clot buster for acute ischaemic stroke

July 24, 2015

News Industry News

Daiichi Sankyo gets EU OK for Lixiana anticoagulant

June 26, 2015

News Daily News

RE-VERSE AD: El Antídoto de Dabigatran, Seguro y Eficaz en un Análisis Provisional

June 25, 2015

News Daily News

RE-VERSE AD: Dabigatran Antidote Appears Safe, Effective in Interim Analysis

June 25, 2015

News Daily News

RE-VERSE AD：中期分析表明达比加群中和剂似乎安全有效

June 25, 2015

News Industry News

Idarucizumab Reverses the Anticoagulant Effect of Dabigatran Within Minutes in Patient Study

June 22, 2015

News Daily News

TAVR后阿司匹林单药疗法的疗效不比DAPT差，可能更安全

May 14, 2015

News Daily News

La Monoterapia con Aspirina Post-TAVR No es Menos Eficaz y es Posiblemente Más Segura que el Tratamiento Antiplaquetario Doble

May 14, 2015

News Industry News

Knowledge Gaps and Misperceptions on Impact of Atrial Fibrillation and Stroke Exist Among Patients, Caregivers and Physicians

May 13, 2015

News Daily News

真实案例研究凸显新抗凝血剂的胃肠道出血风险

L.A. McKeown

May 04, 2015

News Daily News

Real-World Studies Highlight GI Bleeding Concerns With Newer Anticoagulants

L.A. McKeown

May 04, 2015

News Daily News

Estudios del Mundo Exponen que Preocupan las Hemorragias Gastrointestinales secundarias a los Nuevos Anticoagulantes

L.A. McKeown

May 04, 2015

News Daily News

La Fibrilación Auricular Post-IAM Acarrea Malos Resultados

Yael L. Maxwell

May 01, 2015

News Daily News

ISAR-TRIPLE 已发布：6 周与 6 个月三联疗法比较并无净收益

April 29, 2015

News Daily News

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

April 29, 2015

News Daily News

ISAR-TRIPLE Publicado: No hay Beneficio Neto durante 6 Semanas frente a 6 Meses a Tratamiento Triple

April 29, 2015

News Daily News

High-Sensitivity Troponin Assay More Precisely Calibrates Mortality Risk in Suspected ACS Patients

April 20, 2015

News Daily News

药剂师有助于大幅改善达比加群酯依从性

Todd Neale

April 17, 2015

News Daily News

Pharmacists May Help Ameliorate Substantial Variation in Dabigatran Adherence

Todd Neale

April 17, 2015

News Daily News

Los Farmacéuticos Podrían Ayudar a Mejorar la Enorme Variación de la Adherencia al Dabigatran

Todd Neale

April 17, 2015

Advertisement

MHRA review confirms benefit-risk profile of Alteplase - the only licensed clot buster for acute ischaemic stroke

Daiichi Sankyo gets EU OK for Lixiana anticoagulant

RE-VERSE AD: El Antídoto de Dabigatran, Seguro y Eficaz en un Análisis Provisional

RE-VERSE AD: Dabigatran Antidote Appears Safe, Effective in Interim Analysis

RE-VERSE AD：中期分析表明达比加群中和剂似乎安全有效

Idarucizumab Reverses the Anticoagulant Effect of Dabigatran Within Minutes in Patient Study

TAVR后阿司匹林单药疗法的疗效不比DAPT差，可能更安全

La Monoterapia con Aspirina Post-TAVR No es Menos Eficaz y es Posiblemente Más Segura que el Tratamiento Antiplaquetario Doble

Knowledge Gaps and Misperceptions on Impact of Atrial Fibrillation and Stroke Exist Among Patients, Caregivers and Physicians

真实案例研究凸显新抗凝血剂的胃肠道出血风险

Real-World Studies Highlight GI Bleeding Concerns With Newer Anticoagulants

Estudios del Mundo Exponen que Preocupan las Hemorragias Gastrointestinales secundarias a los Nuevos Anticoagulantes

La Fibrilación Auricular Post-IAM Acarrea Malos Resultados

ISAR-TRIPLE 已发布：6 周与 6 个月三联疗法比较并无净收益

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

ISAR-TRIPLE Publicado: No hay Beneficio Neto durante 6 Semanas frente a 6 Meses a Tratamiento Triple

High-Sensitivity Troponin Assay More Precisely Calibrates Mortality Risk in Suspected ACS Patients

药剂师有助于大幅改善达比加群酯依从性

Pharmacists May Help Ameliorate Substantial Variation in Dabigatran Adherence

Los Farmacéuticos Podrían Ayudar a Mejorar la Enorme Variación de la Adherencia al Dabigatran

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content